Peak6 LLC Sarepta Therapeutics, Inc. Transaction History
Peak6 LLC
- $45.9 Billion
- Q4 2024
A detailed history of Peak6 LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Peak6 LLC holds 68,800 shares of SRPT stock, worth $7.46 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
68,800Holding current value
$7.46 Million% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding SRPT
# of Institutions
536Shares Held
87.4MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$1.12 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$985 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$943 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$469 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$441 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.49B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...